Why the study?
Does diabetes increase long-term mortality in patients undergoing contemporary percutaneous coronary intervention?
Population
4,284 patients undergoing contemporary percutaneous coronary intervention at 3 hospitals in New York City.
Comparison
Diabetes mellitus (exposure) vs Non-diabetic patients
Design
Cohort
Follow-up
mean 3 years
Authors
Loading...
Diabetes remains a significant independent predictor of long-term mortality following contemporary PCI, despite the widespread use of stents and GP IIb/IIIa inhibitors.
Does diabetes increase long-term mortality in patients undergoing contemporary percutaneous coronary intervention?
Diabetes remains a significant independent predictor of long-term mortality following contemporary PCI, despite the widespread use of stents and GP IIb/IIIa inhibitors.
Wilson et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: